Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Clinical Diabetes
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Spectrum

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Clinical Diabetes
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Spectrum
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
From Research to Practice

Non-Periodontal Oral Manifestations of Diabetes: A Framework for Medical Care Providers

  1. Beatrice K. Gandara, DDS, MSD and
  2. Thomas H. Morton Jr., DDS, MSD
Diabetes Spectrum 2011 Nov; 24(4): 199-205. https://doi.org/10.2337/diaspect.24.4.199
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Abstract

In Brief

In addition to periodontitis and dental caries, other oral conditions commonly occur commonly in patients with diabetes. These include fungal infections, salivary gland dysfunction, neuropathy, and mucosal disorders. Many of these lesions can be easily examined and documented by non-dental providers.

Evidence that diabetes significantly affects oral tissues is supported by data in an increasing number of publications. Diabetes causes changes in the periodontal tissues, oral mucosa, salivary gland function, and oral neural function and increases the risk for caries.1–5 Additionally, reproductive hormone changes during pregnancy significantly affect periodontal health in women with pre-existing and gestational diabetes.6 These oral manifestations, their mechanisms, and their interrelationships are shown in Figure 1.

Although dental care providers have traditionally played a primary role in the examination and diagnosis of the specific disorders of these tissues, other health care providers who are responsible for diagnosing and managing patients with diabetes and pregnant patients can also easily screen for these oral abnormalities. Changes in oral soft tissues, in addition to periodontal tissues, can be helpful in the diagnosis of diabetes in undiagnosed patients and may serve as aids in monitoring the care of patients with known diabetes.7

The goals of this article are 1) to describe soft-tissue disorders in the oral cavity that are commonly observed in diabetes and can be easily recognized by all health care providers either by history or clinical appearance, and 2) to provide a checklist to facilitate oral examination for these conditions that may also serve as a tool for communication between medical and dental providers. The checklist can also assist providers in informing patients that further oral health evaluation and care are indicated.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Oral manifestations of diabetes and their mechanisms and interrelationships.

The oral tissues most commonly affected by diabetes are the periodontal tissues. This can appear as redness and swelling of the gingiva, bleeding from the gingiva with minor provocation, looseness and spacing of teeth, and exposed root surfaces (at risk for caries) that may or may not carry plaque and mineralized deposits (calculus), depending on the oral hygiene of the individual (Figure 2).5 The significance of occurrence and pathogenic role of periodontitis in diabetes are described elsewhere in this issue (p. 195) and in the scientific literature.8 The focus of this article will be on describing changes in the oral tissues of diabetic patients that include salivary gland dysfunction, mucosal changes, and neuropathy.

Healthy Oral Mucosa

The oral mucosa is normally protected by saliva when it is adequate in amount and quality. Saliva provides lubrication, cleansing, pH buffering, antimicrobial proteins such as secretory IgA, and aggregation and clearance of bacteria.9 The epithelium and minor salivary glands in the mucosa contribute to innate immunity via α- and β-defensins, histatin, and other antimicrobial peptides and proteins.10 These two major features affect the ability of the oral soft tissues to be resilient when challenged by injurious microbes; excessive exposure to mechanical trauma, which can occur if there are jagged edges of broken teeth, defective dental restorations, or poorly fitting dentures; or chemical trauma such as that caused by tobacco and excessive alcohol use. The health of the oral mucosa is also maintained by good nutritional status11 and adequate oral hygiene practices.

Because salivary gland function and immune function are negatively affected by diabetes, diabetic patients are at increased risk for mucosal lesions and other disorders. This has been supported by recent studies showing that oral soft-tissue disease occurs up to 10 times more frequently in patients with diabetes than in non-diabetic patients.1–3,12

Salivary Gland Changes

The oral manifestations of diabetes in the salivary glands include sialoadenosis or noninflammatory, non-neoplastic enlargement of the parotid salivary glands,13–15 decreased salivary flow rates,16,17 and changes in salivary composition.18–20 Bilateral enlargement of the parotid salivary glands has been reported to occur in 10–48% of diabetic patients21,22 and may be more common in patients with poorly controlled diabetes.23

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Periodontal disease.

The enlargements are caused by gradual accumulation of fat in the glands, hypertrophy of the acini or secreting units, and, eventually, impaired glandular secretion. These structural changes may be the result of alteration in autonomic neuroregulation of the glands and atrophy of the myoepithelial cells that facilitate secretion.24 Enlarged parotid glands are also observed in individuals with a history of alcoholism, malnutrition, eating disorders, or medication side effects, and these conditions should be included in a differential diagnosis. However, the pathophysiology of these conditions is different.13,25

Xerostomia, or the sensation of dry mouth, is reported to occur in 40–80% of diabetic patients and is related to decreased salivary flow rates, particularly in unstimulated whole saliva (the combination of secretions from all the salivary glands in the mouth).4,17,21 Flow rates have been reported to be significantly lower in patients with poorly controlled diabetes4,16,17 compared to patients whose diabetes is controlled or nondiabetic patients.

The mechanism by which salivary flow is affected in diabetic patients is thought to be the result of autonomic nerve dysfunction or microvascular changes that diminish the ability of the salivary glands to respond to neural or hormonal stimulation.26,27 Other causes may include dehydration or side effects of concomitant drug therapy commonly used in diabetic patients (e.g., antihypertensives, diuretics, and antidepressants).4,22,28

Low salivary flow rates are significant because saliva provides a protective coating for the oral mucosa that contains antimicrobial proteins and immunoglobulins, buffers acidic foods and liquids, and contains calcium, which is important for mineral exchange at the tooth surface.9 Lack of adequate saliva leads to an increased risk of oral yeast infections, increased caries rate, and difficulty with maintaining oral hygiene, as well as a decrease in quality of life because of discomfort from eating, swallowing, and talking.29

Validated signs and symptoms of an abnormally low salivary flow rate have been described in the literature.30,31 These signs and symptoms (Figure 3) can facilitate the detection of impaired salivary function by health care professionals and support referral to a dental health care provider to manage or provide preventive or intervention care for these conditions.

Mucosal Disorders

Disorders of the oral mucosa commonly occurring in diabetic patients include atrophy of the mucosa, candidiasis (thrush), and lichen planus or lichenoid mucositis.1–3,12 These disorders are related to chronic salivary hypofunction and to the generalized immune dysfunction seen in diabetic patients.

Tongue Abnormalities

After periodontal tissues, the oral site most frequently affected in diabetes is the mucosa of the tongue. Normally, the dorsal surface of the tongue has an even distribution of the filiform and fungiform papilla, giving a textured appearance that is light pink in color. The ventral and lateral surfaces of the normal tongue are smooth, free of papilla, and darker pink in color, occasionally with prominent veins. In a fissured tongue, the smooth texture of the dorsum is interrupted with one or more fissures that are predominantly aligned along the length of the tongue (Figure 4).

This fissuring may be the result of a chronic low salivary flow rate, which alters the environment in the oral cavity such that slow-healing soft tissues are more easily traumatized than in nondiabetic patients.2 A recent study2 of 405 diabetic individuals showed that 5.4% of patients with type 1 diabetes had fissuring of the tongue dorsum compared with 0.4% of control subjects without diabetes (P < 0.0001). In another study of 146 type 2 diabetic patients,1 the rate of fissured tongue was 17.8% compared to 3.6% in the 111 age- and sex-matched control subjects (P < 0.001).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

A checklist to facilitate oral examination by non-dental providers and promote communication between medical and dental providers.

Complete or patchy atrophy of the tongue papilla, resulting in the appearance of a “bald” tongue (Figure 4), is also more common in diabetic patients.3 Generalized atrophy of the papilla of the tongue has been attributed to nutritional deficiencies, particularly if it is very red in appearance.32 Focal areas of atrophy may indicate an infection with candida organisms.33

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Fissured tongue.

A unique condition in which an atrophic “bald” spot is located at the midline, posterior surface of the tongue, anterior to the V-shaped circumvallate papillae, is called median rhomboid glossitis (Figure 5). It is commonly smooth and flat, but may be depressed or have a lobular to papillary surface. It is a recognized manifestation of chronic candidiasis.33

In a study of 176 diabetic patients,33 atrophy of the tongue was found in 26.9% of the patients, with almost all appearing as central papillary atrophy. In another study,3 median rhomboid glossitis was significantly more prevalent in diabetic patients than in nondiabetic patients and was associated with elevated levels of Candida pseudohyphae in oral smears and diabetic complications of nephropathy and retinopathy.

Another condition of the tongue that is more common in diabetic than in nondiabetic patients is geographic tongue, or benign migratory glossitis (Figure 6).1 This condition features focal atrophy of the papilla of the tongue in an irregular “geographic” pattern with characteristic prominent white or yellowish raised borders that “migrate” over time. This condition is not caused by a candida infection but is characterized as inflammation and may also be associated with similar symptoms of pain, itching, and burn ing of the mucosa.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Median rhomboid glossitis.

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

Benign migratory glossitis.

Oral Candidiasis

The combination of a low flow rate and immune dysfunction greatly increases the risk of oral candidiasis, which is supported by the finding of significantly higher rates of candida carriage in patients with diabetes compared to control subjects.2,34 This may also be the result of increased salivary glucose levels, which promote over-growth of Candida,35,36 as well as decreased antifungal immunoglobulins in saliva caused by diabetes.37

Candidiasis may also affect the palatal, buccal, or labial mucosa. Denture stomatitis is a diffuse redness of the mucosa occurring under upper dentures in edentulous patients (Figure 7), particularly when patients complain that their dentures do not fit well.38 The most common symptom is a burning sensation, although patients may also be asymptomatic. This is considered to be a form of candidiasis with the organism actually infecting the porous denture acrylic and causing contact hypersensitivity inflammation of the adjacent mucosa.39

In a study of 110 edentulous individuals with type 2 diabetes compared to 50 control subjects,34 57.3% of the diabetic patients versus 30% of control subjects had denture stomatitis. In another study of 405 subjects with type 1 diabetes compared to 268 non-diabetic patients,3 elevated A1C was shown to be significantly associated with the presence of denture stomatitis or the presence of Candida pseudohyphae in oral swabs.

White areas on oral mucosal surfaces that can be wiped off with cotton gauze leaving a reddened, bleeding surface (without loss of the surface epithelium) are likely to be acute pseudomembranous candidiasis (Figure 8). Typically, patients complain of a burning sensation of the mucosa. If the wiping procedure causes separation of the surface epithelium from the underlying tissues (known as Nikolsky's sign), it is suggestive of a vesiculobullous lesion such as in drug reactions or dermatological autoimmune conditions and requires biopsy for definitive diagnosis.40

Figure 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7.

Denture stomatitis.

Angular cheilitis is redness or fissures at the corners of the mouth involving the junction of the mucosa and skin and may also represent a form of candidiasis (Figure 4).41 This condition occurs significantly more frequently in diabetic than in non-diabetic patients.3,12,34 Other causes of angular cheilitis that should be included in a differential diagnosis include vitamin deficiencies, anemia, staphylococcal infections, and decrease in face height caused by mouth overclosure from loss of teeth.

Oral Lichen Planus and Lichenoid Drug Reactions

White areas of the mucosa that do not wipe off may be a sign of a condition known as lichen planus, a chronic subepithelial inflammatory disorder that results in a characteristic lacey or patch-like white pattern over reddened mucosa (Figure 9). Although its exact etiology is not known, the presence of this mucosal disease has been frequently associated with diabetes.1,42

However, similar mucosal changes called lichenoid drug reactions occur as an adverse side effect to medications that diabetic patients are commonly prescribed.43 These include antihyperglycemic and antihypertensive medications.42 Lichen planus or lichenoid reactions may be symptomatic with pain, burning sensation, and sensitivity to acidic foods. They are associated with an increased risk for dysplastic or cancerous transformation. Therefore, it is important to refer patients with this mucosal change to the dental team for further evaluation.1,12

Figure 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 8.

Acute pseudomembranous candidiasis.

Oral Cancer

Lesions of the dorsal surface of the tongue are unlikely to be cancerous but should be referred to the dental team for diagnosis and treatment. However, the occurrence of a lesion of the lateral or ventral tongue, whether it is white or red or a nonhealing ulceration is always of concern and should be referred immediately to rule out squamous carcinoma.44 This recommendation also applies to lesions occurring in other areas of high cancer risk such as the floor of the mouth and tonsillar areas. Patients with diabetes are at higher risk for oral cancer occurrence than patients without diabetes, particularly if there is a history of chronic smoking and excessive alcohol intake.45–47

Effects of Smoking

There is substantial evidence that the presence of a smoking habit in diabetic patients significantly increases not only the risk of oral cancer, but also the risk periodontal disease48 and mucosal disorders of any type.1,3,5 These factors support frequent thorough oral examinations and regular oral care, as well as smoking cessation programs in the management of oral mucosal and periodontal disease in patients with diabetes who smoke.

Burning Sensation of the Oral Mucosa

A burning sensation of the oral soft tissues is a frequent complaint in diabetic patients, making diabetes the systemic condition most frequently associated with this symptom.49–51 Although oral mucosal conditions such as Candida infections, lichen planus, and dryness can cause burning sensations in diabetic patients,52 a neuropathic basis is supported by observations that the burning sensations in diabetic patients are frequently accompanied by changes in taste (dysgeusia) or other sensory distortions.51,53–55 Additionally, patients with peripheral diabetic neuropathy are more likely to have burning sensations in oral tissues than those without peripheral neuropathy.56 Therefore, questions about sensations of burning in the soft tissues of the oral soft cavity will be helpful to determine the possible presence of candidiasis, lichen planus, oral dryness, or neuropathy, all of which may assist in evaluation of irregular glycemic control.2

Figure 9.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 9.

Lichen planus.

Clinical Oral Health Checklist for Diabetes

Fortunately, most oral tissues can be examined easily and palpated by any health care provider. Good illumination with a lamp, flashlight, headlamp, or otoscope light is important. All surfaces of the tongue should be examined. The tip of the tongue can be gently grasped with a 2-inch cotton gauze square to stabilize and manipulate the tongue, or a wooden tongue depressor may be used to retract, depress, or lift the tongue. The tongue depressor can also be used to retract soft tissues to examine the other oral surfaces, including the buccal and labial mucosa, floor of mouth, hard and soft palate, periodontium, and teeth. White areas on the surface of the mucosa should be wiped with a gauze square to see if they wipe off or indicate an integral mucosal alteration.

Figure 3 offers a sample checklist containing items to assist health care team members in detecting and documenting oral findings that can contribute to the diagnosis of diabetes and management of diabetic patients. Additionally, this checklist can be the basis of a structured referral form in an electronic health record that can be used for communication between the medical and dental care providers, keeping in mind that, for any form to be successful, the care providers must discuss mutual expectations and agree on what constitutes effective and efficient communication for their particular relationship.57

We recommend that the clinical standard of comprehensive care for diabetic patients should include, at a minimum, a yearly screening of oral health status by medical providers, similar to the screening frequency for eye and foot health.58 If patients have one or more of the findings on the checklist, they should be evaluated for level of glycemic control and referred to a dentist for evaluation and care of the oral condition.59 Yearly or more frequent prophylactic care, including dental cleanings, restorative work as needed, and oral hygiene instruction by a dental team, is also recommended, depending on the oral health status and glycemic control of the patient.

Conclusion

In addition to periodontitis, certain non-periodontal oral lesions and conditions have been associated with and are commonly observed in patients with diabetes. These include oral dryness, caries, burning mouth sensation or other neuropathy, enlarged parotid glands, atrophic or lichenoid mucosal changes, and mucosal infection such as candidiasis.

We have included photos, a diagram to help illustrate the oral manifestations of diabetes, and a checklist to help non-dental health care providers evaluate patients' oral signs and symptoms of diabetes and monitor therapy. The checklist also provides criteria for the clinical recognition of oral lesions that may occur in undiagnosed diabetes. It can and should be customized to suit the needs of specific health care teams to deliver care efficiently and to obtain the best oral and systemic health outcomes for their patients.

Footnotes

  • Beatrice K. Gandara, DDS, MSD, is a clinical associate professor in the Department of Oral Medicine at the University of Washington School of Medicine in Seattle. Thomas H. Morton, Jr., DDS, MSD, is a professor emeritus at the same institution.

  • American Diabetes Association(R) Inc., 2011

References

  1. ↵
    1. de Souza Bastos A,
    2. Leite AR,
    3. Spin-Neto R,
    4. Nassar PO,
    5. Massucato EM,
    6. Orrico SR
    : Diabetes mellitus and oral mucosa alterations: prevalence and risk factors. Diabetes Res Clin Pract 92:100–105, 2011
    OpenUrlPubMed
  2. ↵
    1. Guggenheimer J,
    2. Moore PA,
    3. Rossie K,
    4. Myers D,
    5. Mongelluzzo MB,
    6. Block HM,
    7. Weyant R,
    8. Orchard T
    : Insulin-dependent diabetes mellitus and oral soft tissue pathologies. I. Prevalence and characteristics of non-candidal lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89:563–569,
  3. ↵
    1. Guggenheimer J,
    2. Moore PA,
    3. Rossie K,
    4. Myers D,
    5. Mongelluzzo MB,
    6. Block HM,
    7. Weyant R,
    8. Orchard T
    : Insulin-dependent diabetes mellitus and oral soft tissue pathologies: II. Prevalence and characteristics of Candida and Candidal lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89:570–576, 2000
    OpenUrlPubMedWeb of Science
  4. ↵
    1. Moore PA,
    2. Guggenheimer J,
    3. Etzel KR,
    4. Weyant R,
    5. Orchard T
    : Type 1 diabetes mellitus, xerostomia, and salivary flow rates. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92:281–291, 2001
    OpenUrlCrossRefPubMed
  5. ↵
    1. Sandberg GE,
    2. Sundberg HE,
    3. Fjellstrom CA,
    4. Wikblad KF
    : Type 2 diabetes and oral health: a comparison between diabetic and non-diabetic subjects. Diabetes Res Clin Pract 50:27–34, 2000
    OpenUrlPubMedWeb of Science
  6. ↵
    1. Xiong X,
    2. Buekens P,
    3. Vastardis S,
    4. Pridjian G
    : Periodontal disease and gestational diabetes mellitus. Am J Obstet Gynecol 195:1086–1089, 2006
    OpenUrlPubMedWeb of Science
  7. ↵
    1. Mealey BL
    : The interactions between physicians and dentists in managing the care of patients with diabetes mellitus. J Am Dent Assoc 139 (Suppl. 5):4S–7S, 2008
    OpenUrlFREE Full Text
  8. ↵
    1. Lamster IB,
    2. Lalla E,
    3. Borgnakke WS,
    4. Taylor GW
    : The relationship between oral health and diabetes mellitus. J Am Dent Assoc 139 (Suppl. 5):19S–24S, 2008
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Edgar M,
    2. Dawes C,
    3. O'Mullane D
    1. Whelton H
    : Functions of saliva. In Saliva and Oral Health, 3rd ed. Edgar M, Dawes C, O'Mullane D, Eds. London, British Dental Association, 2004, p. 3
  10. ↵
    1. Dale BA,
    2. Fredericks LP
    : Antimicrobial peptides in the oral environment: expression and function in health and disease. Curr Issues Mol Biol 7:119–133, 2005
    OpenUrlPubMedWeb of Science
  11. ↵
    1. Moynihan PJ
    : The role of diet and nutrition in the etiology and prevention of oral diseases. Bull World Health Organ 83:694–649, 2005
    OpenUrlPubMed
  12. ↵
    1. Saini R,
    2. Al-Maweri SA,
    3. Saini D,
    4. Ismail NM,
    5. Ismail AR
    : Oral mucosal lesions in non-oral habit diabetic patients and association of diabetes mellitus with oral precancerous lesions. Diabetes Res Clin Pract 89:320–326, 2010
    OpenUrlPubMed
  13. ↵
    1. Carda C,
    2. Mosquera-Lloreda N,
    3. Salom L,
    4. Gomez de Ferraris ME,
    5. Peydró Az
    : Structural and functional salivary disorders in type 2 diabetic patients. Med Oral Patol Oral Cir Bucal 11:E309–E314, 2006
    OpenUrlPubMed
    1. Davidson D,
    2. Leibel B,
    3. Berris B
    : Asymptomatic parotid gland enlargement in diabetes mellitus. Ann Intern Med 70:31–38, 1969
    OpenUrlPubMedWeb of Science
  14. ↵
    1. Neville BW,
    2. Damm DD,
    3. Allen CM,
    4. Bouquet JE
    (eds.): Oral and maxillo facial pathology. Philadelpia, Pa., Saunders, 2002, p. 404–405
  15. ↵
    1. Chavez EM,
    2. Taylor GW,
    3. Borrell LN,
    4. Ship JA
    : Salivary function and glycemic control in older persons with diabetes. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89:305–311, 2000
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Sreebny LM,
    2. Yu A,
    3. Green A,
    4. Valdini A
    : Xerostomia in diabetes mellitus. Diabetes Care 15:900–904, 1992
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Dodds MWJ,
    2. Yeh C,
    3. Johnson DA
    : Salivary alterations in type 2 (non-insulin-dependent) diabetes mellitus and hypertension. Community Dent Oral Epidemiol 28:373–381, 2000
    OpenUrlCrossRefPubMedWeb of Science
    1. Jawed M,
    2. Shahid SM,
    3. Qader SA,
    4. Azhar A
    : Dental caries in diabetes mellitus: role of salivary flow rate and minerals. J Diabetes Complications 25:183–186, 2011
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    1. Mata AD,
    2. Marques D,
    3. Rocha S,
    4. Francisco H,
    5. Santos C,
    6. Mesquita MF,
    7. Singh J
    : Effects of diabetes mellitus on salivary secretion and its composition in the human. Mol Cell Biochem 261:137–142, 2004
    OpenUrlCrossRefPubMed
  19. ↵
    1. Lalla RV,
    2. D'Ambrosio JA
    : Dental management considerations for the patient with diabetes mellitus. J Am Dent Assoc 132:1425–1432, 2001
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Manfredi M,
    2. McCullough MJ,
    3. Vescovi P,
    4. Al-Kaarawi ZM,
    5. Porter SR
    : Update on diabetes mellitus and related oral diseases. Oral Dis 10:187–200, 2004
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    1. Russotto SB
    : Asymptomatic parotid gland enlargement in diabetes mellitus. Oral Surg Oral Med Oral Pathol 52:594–598, 1981
    OpenUrlCrossRefPubMed
  22. ↵
    1. Carda C,
    2. Carranza M,
    3. Arriaga A,
    4. Díaz A,
    5. Peydró A,
    6. Gomez de Ferraris ME
    : Structural differences between alcoholic and diabetic parotid sialosis. Med Oral Patol Oral Cir Bucal 10:309–314, 2005
    OpenUrlPubMed
  23. ↵
    1. Scully C,
    2. Bagán JV,
    3. Eveson JW,
    4. Barnard N,
    5. Turner FM
    : Sialosis: 35 cases of persistent parotid swelling from two countries. Br J Oral Maxillofac Surg 46:468–472, 2008
    OpenUrlCrossRefPubMed
  24. ↵
    1. Garrett JR,
    2. Ekström J,
    3. Anderson LC
    1. Anderson L
    : Hormonal regulation of salivary glands, with particular reference to experimental diabetes. In Glandular Mechanisms of Salivary Secretion: Frontiers of Oral Biology, vol. 10. Garrett JR, Ekström J, Anderson LC, Eds. Basel, Switzerland, Karger, 1998, p. 200–221
    OpenUrl
  25. ↵
    1. Newrick PG,
    2. Bowman C,
    3. Green D,
    4. O'Brien IA,
    5. Porter SR,
    6. Scully C,
    7. Corrall RJ
    : Parotid salivary secretion in diabetic autonomic neuropathy. J Diabetes Complications 5:35–37, 1991
    OpenUrlCrossRef
  26. ↵
    1. Meurman JH,
    2. Collin H,
    3. Niskanen L,
    4. Töyry J,
    5. Alakuijala P,
    6. Keinänen S,
    7. Uusitupa M
    : Saliva in non-insulin-dependent diabetic patients and control subjects. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 86:69–76, 1998
    OpenUrl
  27. ↵
    1. Sreebny LM,
    2. Vissink A
    : Dry Mouth, The Malevolent Symptom: A Clinical Guide. Hoboken, N.J., Wiley-Blackwell, 2010.
  28. ↵
    1. Fox PC,
    2. Busch KA,
    3. Baum BJ
    : Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc 115:581–584, 1987
    OpenUrlAbstract
  29. ↵
    1. Navazesh M,
    2. Christensen C,
    3. Brightman V
    : Clinical criteria for the diagnosis of salivary gland hypofunction. J Dent Res 71:1363–1369, 1992
    OpenUrlAbstract/FREE Full Text
  30. ↵
    1. Touger-Decker R,
    2. Sirois D,
    3. Mobley CC
    1. Moynihan PJ,
    2. Lingström P
    : Oral consequences of compromised nutritional well-being. In Nutrition and Oral Medicine. Touger-Decker R, Sirois D, Mobley CC, Eds. Totowa, N.J., Humana Press, 2004, p. 107–127
  31. ↵
    1. Farman AG
    : Atrophic lesions of the tongue: a prevalence study among 176 diabetic patients. J Oral Pathol 5:255–264, 1976
    OpenUrlPubMed
  32. ↵
    1. Dorocka-Bobkowska B,
    2. Zozulinska-Ziolkiewicz D,
    3. Wierusz-Wysocka B,
    4. Hedzelek W,
    5. Szumala-Kakol A,
    6. Budtz-Jörgensen E
    : Candida-associated denture stomatitis in type 2 diabetes mellitus. Diabetes Res Clin Pract 90:81–86, 2010
    OpenUrlPubMed
  33. ↵
    1. Knight L,
    2. Fletcher J
    : Growth of Candida albicans in saliva: stimulation by glucose associated with antibiotics, corticosteroids, and diabetes mellitus. J Infect Dis 123:371–377, 1971
    OpenUrlFREE Full Text
  34. ↵
    1. Sashikumar R,
    2. Kannan R
    : Salivary glucose levels and oral candidal carriage in type II diabetics. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109:706–711, 2010
    OpenUrlPubMed
  35. ↵
    1. Samaranayake LP,
    2. MacFarlane TW
    1. Samaranayake LP
    : Host factors and oral candidosis. In Oral Candidosis. Samaranayake LP, MacFarlane TW, Eds. London, Wright, 1990, p. 66–103
  36. ↵
    1. Emami E,
    2. de Grandmont P,
    3. Rompré PH,
    4. Barbeau J,
    5. Pan S,
    6. Feine JS
    : Favoring trauma as an etiological factor in denture stomatitis. J Dent Res 87:440–444, 2008
    OpenUrlAbstract/FREE Full Text
  37. ↵
    1. Davenport JC,
    2. Wilton JMA
    : Incidence of immediate and delayed hypersensitivity to Candida albicans in denture stomatitis. J Dent Res 50:892–896, 1971
    OpenUrlAbstract/FREE Full Text
  38. ↵
    1. Bickle KM,
    2. Roark TR,
    3. Hsu S
    : Autoimmune bullous dermatoses: a review. Am Fam Phys 65:1861–1871, 2002
    OpenUrlPubMedWeb of Science
  39. ↵
    1. Samaranayake LP,
    2. MacFarlane TW
    1. Budtz-Jørgensen E
    : Candida-associated denture stomatitis and angular cheilitis. In Oral Candidosis. Samaranayake LP, MacFarlane TW, Eds. London, Wright, 1990, p 156–183
  40. ↵
    1. Romero MA,
    2. Seoane J,
    3. Varela-Centelles P,
    4. Diz-Dios P,
    5. Garcia-Pola MJ
    : Prevalence of diabetes mellitus amongst oral lichen planus patients: clinical and pathological characteristics. Med Oral 7:121–129, 2002
    OpenUrlPubMed
  41. ↵
    1. Kaomongkolgit R
    : Oral lichenoid drug reaction associated with antihypertensive and hypoglycemic drugs. J Drugs Dermatol 9:73–75, 2010
    OpenUrlPubMed
  42. ↵
    1. Reamy BV,
    2. Derby R,
    3. Bunt CW
    : Common tongue conditions in primary care. Am Fam Phys 81:627–634, 2010
    OpenUrlPubMedWeb of Science
  43. ↵
    1. Ujpál M,
    2. Matos O,
    3. Bíbok G,
    4. Somogyi A,
    5. Szabó G,
    6. Suba Z
    : Diabetes and oral tumors in Hungary: epidemiological correlations. Diabetes Care 27:770–774, 2004
    OpenUrlAbstract/FREE Full Text
    1. Goutzanis L,
    2. Vairaktaris E,
    3. Yapijakis C,
    4. Kavantzas,
    5. Nkenke E,
    6. Derka S,
    7. Vassiliou S,
    8. Acil Y,
    9. Kessler P,
    10. Stavrianeas N,
    11. Perrea D,
    12. Donta I,
    13. Skandalakis P,
    14. Patsouris E
    : Diabetes may increase risk for oral cancer through the insulin receptor substrate-1 and focal adhesion kinase pathway. Oral Oncol 43:165–173, 2007
    OpenUrlPubMed
  44. ↵
    1. Zygogianni AG,
    2. Kyrgias G,
    3. Karakitsos P,
    4. Psyrri A,
    5. Kouvaris J,
    6. Kelekis N,
    7. Kouloulias V
    : Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol 3:2, 2011. Electronically published (DOI: 10.1186/1758-3284-3-2). Available online from www.headandneckoncology.org/content/3/1/2
    OpenUrlCrossRefPubMed
  45. ↵
    1. Moore PA,
    2. Weyant RJ,
    3. Mongelluzzo MB,
    4. Myers DE,
    5. Rossie K,
    6. Guggenheimer J,
    7. Block HM,
    8. Huber H,
    9. Orchard T
    : Type 1 diabetes mellitus and oral health: assessment of periodontal disease. J Periodontol 70:409–417, 1999
    OpenUrlPubMed
  46. ↵
    1. Basker RM,
    2. Strudee DW,
    3. Davenport JC
    : Patients with burning mouths: a clinical investigation of causative factors, including climacteric and diabetes. Brit Dent J 145:9–16, 1978
    OpenUrlPubMed
    1. Carrington J,
    2. Getter L,
    3. Brown RS
    : Diabetic neuropathy masquerading as glossodynia. J Am Dent Assoc 132:1549–1551, 2001
    OpenUrlAbstract/FREE Full Text
  47. ↵
    1. Collin HL,
    2. Niskanen L,
    3. Uusitupa M,
    4. Tfyry J,
    5. Collin P,
    6. Koivisto AM,
    7. Viinamäki H,
    8. Meurman JH
    : Oral symptoms and signs in elderly patients with type 2 diabetes mellitus: a focus on diabetic neuropathy. Oral Surg Oral Med Oral Path Oral Radiol Endodontol 90:299–305, 2000
    OpenUrl
  48. ↵
    1. Scala A,
    2. Checchi L,
    3. Montevecchi M,
    4. Marini I,
    5. Giamberardino MA
    : Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med 14:275–291, 2003
    OpenUrlAbstract/FREE Full Text
  49. ↵
    1. Arap A,
    2. Siqueira SRDT,
    3. Silva CB,
    4. Teixeira MJ,
    5. Siqueira JTT
    : Trigeminal pain and quantitative sensory testing in painful peripheral diabetic neuropathy. Arch Oral Biol 55:486–493, 2010
    OpenUrlPubMed
    1. Formaker BK,
    2. Frank ME
    : Taste function in patients with oral burning. Chem Senses 25:575–581, 2000
    OpenUrlAbstract/FREE Full Text
  50. ↵
    1. Grushka M,
    2. Sessle BJ,
    3. Howley TP
    : Psychophysical assessment of tactile, pain and thermal sensory functions in burning mouth syndrome. Pain 28:169–184, 1987
    OpenUrlCrossRefPubMedWeb of Science
  51. ↵
    1. Moore PA,
    2. Guggenheimer J,
    3. Orchard T
    : Burning mouth syndrome and peripheral neuropathy in patients with type 1 diabetes mellitus. J Diabetes Complications 21:397–402, 2007
    OpenUrlPubMed
  52. ↵
    1. Wagner Ed
    : The patient-centered medical home: care coordination [article online]. Available from http://www.qhmedicalhome.org/safety-net/upload/Webinar_CareCoordinationinthePCMH_011911.pdf. Accessed 20 June 2011
  53. ↵
    1. American Diabetes Association
    : Standards of Medical Care in Diabetes—2011. Diabetes Care 34 (Suppl. 1):S11–S61, 2011
    OpenUrlFREE Full Text
  54. ↵
    1. Moore PA,
    2. Zgibor JC,
    3. Dasanayake AP
    : Diabetes: a growing epidemic of all ages. J Am Dent Assoc 134 (Suppl. 1):11S–15S, 2003
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Diabetes Spectrum: 24 (4)

In this Issue

November 2011, 24(4)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Spectrum.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Non-Periodontal Oral Manifestations of Diabetes: A Framework for Medical Care Providers
(Your Name) has forwarded a page to you from Diabetes Spectrum
(Your Name) thought you would like to see this page from the Diabetes Spectrum web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Non-Periodontal Oral Manifestations of Diabetes: A Framework for Medical Care Providers
Beatrice K. Gandara, Thomas H. Morton
Diabetes Spectrum Nov 2011, 24 (4) 199-205; DOI: 10.2337/diaspect.24.4.199

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Non-Periodontal Oral Manifestations of Diabetes: A Framework for Medical Care Providers
Beatrice K. Gandara, Thomas H. Morton
Diabetes Spectrum Nov 2011, 24 (4) 199-205; DOI: 10.2337/diaspect.24.4.199
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Healthy Oral Mucosa
    • Salivary Gland Changes
    • Mucosal Disorders
    • Tongue Abnormalities
    • Oral Candidiasis
    • Oral Lichen Planus and Lichenoid Drug Reactions
    • Oral Cancer
    • Effects of Smoking
    • Burning Sensation of the Oral Mucosa
    • Clinical Oral Health Checklist for Diabetes
    • Conclusion
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Management of Diabetes Across the Life Spectrum
  • About Medha N. Munshi, MD: Guest Editor, Management of Diabetes Across the Life Spectrum
  • Challenges and Strategies for Managing Diabetes in the Elderly in Long-Term Care Settings
Show more From Research to Practice

Similar Articles

Navigate

  • Current Issue
  • Papers in Press
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Diabetes Care
  • Clinical Diabetes
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Spectrum Print ISSN: 1040-9165, Online ISSN: 1944-7353.